2015
Founded
About
Cellective BioTherapy is a preclinical-stage biotechnology company developing first-in-class regulatory B10 cell-based immunotherapies for cancer, autoimmunity and immunosuppression.
Explore cellective's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.